LIGAND PHARMACEUTICALS INCORPORATED Derivative Asset
LIGAND PHARMACEUTICALS INCORPORATED (LGND) had Derivative Asset of $18.84 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets
us-gaap:DerivativeAssets · last filed 2026-08-07
- 2026-06-30: Derivative Asset $18.84M.
- 2026-03-31: Derivative Asset $14.79M.
- 2025-12-31: Derivative Asset $15.63M.
- 2024-12-31: Derivative Asset $10.58M.
| Period end | Derivative Asset |
|---|---|
| 2026-06-30 | $18.84M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $14.79M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $15.63M 10-Q · filed 2026-08-07 |
| 2024-12-31 | $10.58M 10-K · filed 2026-02-27 |